TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 70 filers reported holding TRINITY BIOTECH PLC in Q3 2013. The put-call ratio across all filers is 0.06 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $170,000 | -0.6% | 24,591 | +67.4% | 0.01% | -9.1% |
| Q1 2016 | $171,000 | +6.2% | 14,691 | +7.1% | 0.01% | +37.5% |
| Q4 2015 | $161,000 | -46.3% | 13,713 | -19.9% | 0.01% | -61.9% |
| Q4 2014 | $300,000 | -38.5% | 17,119 | -19.2% | 0.02% | -4.5% |
| Q2 2014 | $488,000 | +54.9% | 21,200 | +63.1% | 0.02% | 0.0% |
| Q1 2014 | $315,000 | +56.7% | 13,000 | +62.5% | 0.02% | +37.5% |
| Q4 2013 | $201,000 | -17.6% | 8,000 | -44.8% | 0.02% | -44.8% |
| Q2 2013 | $244,000 | – | 14,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
| ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
| Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
| GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
| Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
| Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
| Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
| Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
| Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
| HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |